Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Beta-carotene 9',10'-oxygenase (BCO2) is a mitochondrial enzyme belonging to the carotenoid cleavage dioxygenase (CCD) family, primarily responsible for the asymmetric (eccentric) cleavage of carotenoids [UniProt: Q9BYV7]. While its cytoplasmic counterpart BCO1 performs the central cleavage of beta-carotene to produce vitamin A, BCO2 acts on a broader range of substrates, including non-provitamin A xanthophylls like lutein and zeaxanthin, converting them into apo-carotenoids [PubMed: 11435451]. This enzymatic activity is crucial for maintaining mitochondrial integrity, as the accumulation of intact carotenoids in the inner mitochondrial membrane can disrupt the electron transport chain and induce oxidative stress [PubMed: 21953444]. Clinically, BCO2 deficiency or genetic polymorphism is associated with hypercarotenemia, characterized by yellow skin pigmentation, and has been implicated in the pathogenesis of hepatic steatosis and age-related macular degeneration [PubMed: 24659303, PubMed: 22535975]. Although no small-molecule drugs currently target BCO2 in clinical practice, it is a focal point for developing precision nutrition strategies and understanding the metabolic flux of dietary antioxidants.
Catalyzes the asymmetric (eccentric) oxidative cleavage of the 9',10' double bond in carotenoids, such as beta-carotene and xanthophylls, to produce apo-carotenoids.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Beta-carotene 9',10'-oxygenase (BCO2).